TFRI welcomes new investment at CancerCare Manitoba
Vancouver -- News that the Province of Manitoba is investing $70 million to create a new, state-of-the-art facility for CancerCare Manitoba is welcomed enthusiastically by the Terry Fox Research Institute. CancerCare Manitoba is one of TFRI's partners in its newly established Prairie node.
"We congratulate the Province of Manitoba and CancerCare Manitoba for this tremendous investment and commitment which will greatly benefit cancer patients in the province," said TFRI President and Scientific Director Dr. Victor Ling. "TFRI will also benefit from this new investment. It will strengthen our regional node by providing top-notch facilities and space for clinicians and scientists, including those associated with TFRI."
Prairie Node Leader Dr. Jim Davie, senior scientist, Manitoba Institute of Cell Biology, and professor, Department of Biochemistry and Medical Genetics, University of Manitoba, says the new facility will enhance a number of research areas including colorectal cancer, molecular and genetic testing, and cell biology, as well as facilitate access to emerging cancer therapies and leading-edge medical care.
Manitoba Premier Greg Selinger announced April 13, 2011 that the funding will improve diagnostics, treatment and research that will help all Manitobans affected by the disease.
Are you looking for information about a Terry Fox-funded research project? You can access information about our projects through an online database. The information is available from the Canadian Institutes for Health Research's searchable database and appear on the national Canadian Research Information System (CRIS) database. The database is searchable by subject, investigator, funding, location or program.
